Peking Union Medical College Hospital赞助的临床试验
总计2835个结果
-
Peking Union Medical College Hospital未知
-
Peking Union Medical College Hospital未知
-
Peking Union Medical College Hospital招聘中
-
Peking Union Medical College Hospital招聘中
-
Peking Union Medical College Hospital招聘中
-
Peking Union Medical College Hospital招聘中
-
Peking Union Medical College Hospital招聘中
-
Peking Union Medical College Hospital招聘中
-
Peking Union Medical College Hospital尚未招聘Surufatinib 联合 Envafolimab 作为晚期软组织肉瘤患者的二线或更多线治疗的疗效和安全性